Oncology Views & Analysis

Views & Analysis

ASCO 2018 Preview – what to expect from this year’s conferen...

pharmaphorum will be presenting live online coverage of this year’s ASCO 2018 conference, the biggest event of the year for cancer medicine.

Views & Analysis

Bahija Jallal: pharma’s Woman of the Year in a landmark 12 m...

AstraZeneca’s Bahija Jallal was named the Healthcare Businesswomen’s Association (HBA) Women of the Year for 2017 – in what turned out to a watershed year for women’s rights.

Views & Analysis

Improving oncology KOL engagement

Combining technology with human insights is a powerful tool in identifying and engaging effectively with oncology experts.

Views & Analysis

Kite and Sangamo come together in $3bn cancer gene editing a...

Two pioneers in the parallel technologies of cell therapy and gene therapy have come together in an ambitious alliance to develop new cancer therapies.

Views & Analysis

Executives walking inside gears at sea at dawn demonstrate the power of cooperation and synergy.

The Cancer Vanguard: NHS and pharma partnership improves pat...

The Pharma Challenge saw Amgen, Merck, IQVIA and uMotif collaborate with the NHS on a range of projects to improve care for cancer patients.

Views & Analysis

CAR-Ts dominated the agenda at ASH 2017

The American Society for Hematology congress was dominated by CAR-T therapies – their potential new uses, how to manage safety issues and bring these costly cellular treatments to patients.

ASCO 2018 Preview – what to expect from this year’s conferen...

Bahija Jallal: pharma’s Woman of the Year in a landmark 12 m...

Improving oncology KOL engagement

Kite and Sangamo come together in $3bn cancer gene editing a...

The Cancer Vanguard: NHS and pharma partnership improves pat...

CAR-Ts dominated the agenda at ASH 2017

Making direct-to-patient work, with Matt Wadyka

Using AI-driven synthetic personas to take your insights fur...

Views & Analysis

Editor's Picks